Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Respir Med ; 181: 106384, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-33839587

RESUMO

BACKGROUND: While lung ultrasonography (LUS) has utility for the evaluation of the acute phase of COVID-19 related lung disease, its role in long-term follow-up of this condition has not been well described. The objective of this study is to compare LUS and chest computed tomography (CT) results in COVID-19 survivors with the intent of defining the utility of LUS for long-term follow-up of COVID-19 respiratory disease. METHODS: Prospective observational study that enrolled consecutive survivors of COVID-19 with acute hypoxemic respiratory failure (HARF) admitted to the Respiratory Intensive Care Unit. Three months following hospital discharge, patients underwent LUS, chest CT, body plethysmography and laboratory testing, the comparison of which forms the basis of this report. RESULTS: 38 patients were enrolled, with a total of 190 lobes analysed: men 27/38 (71.1%), mean age 60.6 y (SD 10.4). LUS findings and pulmonary function tests outcomes were compared between patients with and without ILD, showing a statistically significant difference in terms of LUS score (p: 0.0002), FEV1 (p: 0.0039) and FVC (p: 0.012). ROC curve both in lobe by lobe and in patient's overall analysis revealed an outstanding ILD discrimination ability of LUS (AUC: 0.94 and 0.95 respectively) with a substantial Cohen's coefficient (K: 0.74 and 0.69). CONCLUSIONS: LUS has an outstanding discrimination ability compared to CT in identifying an ILD of at least mild grade in the post COVID-19 follow-up. LUS should be considered as the first-line tool in follow-up programs, while chest CT could be performed based on LUS findings.


Assuntos
COVID-19/diagnóstico por imagem , Pulmão/diagnóstico por imagem , Insuficiência Respiratória/diagnóstico por imagem , Sobreviventes , Ultrassonografia , Idoso , COVID-19/complicações , Feminino , Seguimentos , Humanos , Doenças Pulmonares Intersticiais/diagnóstico por imagem , Doenças Pulmonares Intersticiais/etiologia , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Testes de Função Respiratória , Insuficiência Respiratória/etiologia , Fatores de Tempo , Tomografia Computadorizada por Raios X
2.
Appl Spectrosc ; 70(1): 186-96, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26767644

RESUMO

To date, little attention has been given to the scientific investigation of modern and contemporary mural paintings. This paper reports on: (1) the in situ spectroscopic analyses of the mural Tuttomondo (1989) painted by Keith Haring (1958-1990) in Pisa (Italy); and (2) the laboratory characterization of acrylic paints produced by Caparol Italy GmbH & Co., the original supplier of paint materials to the artist for the mural. Ultraviolet (UV), visible (Vis), and near-infrared (NIR) fiber optic reflectance spectroscopy (FORS) measurements were carried out in situ. The Caparol paint samples were characterized using benchtop instrumentation including both dispersive and Fourier transform Raman spectroscopy, Fourier transform infrared spectroscopy (FT-IR; with sample pre-treatment to remove filler interference in the fingerprint region), and UV-Vis-NIR FORS. This combined analytical approach confirmed that the materials used by Haring for the mural Tuttomondo have the same composition of the new Caparol acrylic paints, except for the case of the yellow pigment. This information offers valuable documentation for the materials history and for the conservation of a mural painting that is considered the last great public work by Haring.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...